Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Nov 28, 2017; 23(44): 7888-7898
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7888
Figure 4
Figure 4 Correlations of miR-125a/b expression with disease severity in patients with Crohn's disease in remission. A-C: Correlations of miR-125a expression with disease severity in R-CD patients; D-F: Correlations of miR-125b expression with disease severity in R-CD patients. Spearman’s test was used to analyse the correlation of miR-125a/b expression with disease severity. P < 0.05 was considered significant. A-CD: Active Crohn's disease; R-CD: Crohn's disease in remission; HCs: Healthy controls.